- Home
- LODE vs IMMX Comparison
LODE vs IMMX Comparison
Compare LODE & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LODE
- IMMX
- Stock Information
- Founded
- LODE 2008
- IMMX 2014
- Country
- LODE United States
- IMMX United States
- Employees
- LODE N/A
- IMMX N/A
- Industry
- LODE Major Chemicals
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- LODE Industrials
- IMMX Health Care
- Exchange
- LODE Nasdaq
- IMMX Nasdaq
- Market Cap
- LODE 53.0M
- IMMX 61.1M
- IPO Year
- LODE N/A
- IMMX 2021
- Fundamental
- Price
- LODE $3.28
- IMMX $2.72
- Analyst Decision
- LODE Buy
- IMMX Strong Buy
- Analyst Count
- LODE 1
- IMMX 1
- Target Price
- LODE $26.00
- IMMX $7.00
- AVG Volume (30 Days)
- LODE 400.5K
- IMMX 214.1K
- Earning Date
- LODE 08-11-2025
- IMMX 08-11-2025
- Dividend Yield
- LODE N/A
- IMMX N/A
- EPS Growth
- LODE N/A
- IMMX N/A
- EPS
- LODE N/A
- IMMX N/A
- Revenue
- LODE $3,376,027.00
- IMMX N/A
- Revenue This Year
- LODE $24.69
- IMMX N/A
- Revenue Next Year
- LODE N/A
- IMMX N/A
- P/E Ratio
- LODE N/A
- IMMX N/A
- Revenue Growth
- LODE 102.20
- IMMX N/A
- 52 Week Low
- LODE $1.26
- IMMX $1.26
- 52 Week High
- LODE $10.10
- IMMX $3.20
- Technical
- Relative Strength Index (RSI)
- LODE 41.24
- IMMX 53.11
- Support Level
- LODE $3.32
- IMMX $2.63
- Resistance Level
- LODE $3.58
- IMMX $3.20
- Average True Range (ATR)
- LODE 0.23
- IMMX 0.23
- MACD
- LODE -0.06
- IMMX -0.04
- Stochastic Oscillator
- LODE 1.47
- IMMX 15.64
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.